DC Funds, LP — Q3 2025 13F-HR

← DC Funds, LP

Q3 2025 · 13F-HR

DC Funds, LPholdings as filed

Filed 2025-11-10 · accession 0001398344-25-020563

$3.1M

Reported value

Positions

2025-09-30

Period end

View analyzed profile →PRO

The Brief · DC Funds, LP · Q3 2025

AI · grounded in 13F

DC Funds, LP established three new positions to reach a total AUM of $3,109,886. The fund's largest move was a $1,160,531 investment in Werewolf Therapeutics Inc HOWL. It also initiated positions in Tscan Therapeutics Inc TCRX for $1,146,600 and Barinthus Biotherapeutics PL BRNS for $802,755.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
95075A107	HOWL	WEREWOLF THERAPEUTICS INC	$1.2M	37.3%	589,102	Common	SOLE
89854M101	TCRX	TSCAN THERAPEUTICS INC	$1.1M	36.9%	630,000	Common	SOLE
91864C107	BRNS	BARINTHUS BIOTHERAPEUTICS PL	$802,755	25.8%	642,204	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.